Research output per year
Research output per year
- 15 results
Search results
-
2025
STAT5 Activation Enhances Adoptive Therapy Combined with Peptide Vaccination by Preventing PD-1 Inhibition
Fan, A. E., Sultan, H., Kumai, T., Fesenkova, V. I., Wu, J., Klement, J. D., Bernstock, J. D., Friedman, G. K. & Celis, E., Mar 1 2025, In: Molecular Cancer Therapeutics. 24, 3, p. 419-430 12 p.Research output: Contribution to journal › Article › peer-review
-
2024
IL2 Targeted to CD8+ T Cells Promotes Robust Effector T-cell Responses and Potent Antitumor Immunity
Moynihan, K. D., Kumar, M. P., Sultan, H., Pappas, D. C., Park, T., Chin, S. M., Bessette, P., Lan, R. Y., Nguyen, H. C., Mathewson, N. D., Ni, I., Chen, W., Lee, Y., Liao-Chan, S., Chen, J., Schumacher, T. N. M., Schreiber, R. D., Yeung, Y. A. & Djuretic, I. M., Jul 1 2024, In: Cancer discovery. 14, 7, p. 1206-1225 20 p.Research output: Contribution to journal › Article › peer-review
Open Access16 Scopus citations -
Improvement of Tumor Neoantigen Detection by High-Field Asymmetric Waveform Ion Mobility Mass Spectrometry
Meng, W., Takeuchi, Y., Ward, J. P., Sultan, H., Arthur, C. D., Mardis, E. R., Artyomov, M. N., Lichti, C. F. & Schreiber, R. D., Aug 2024, In: Cancer immunology research. 12, 8, p. 988-1006 19 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy
Sultan, H., Takeuchi, Y., Ward, J. P., Sharma, N., Liu, T. T., Sukhov, V., Firulyova, M., Song, Y., Ameh, S., Brioschi, S., Khantakova, D., Arthur, C. D., White, J. M., Kohlmiller, H., Salazar, A. M., Burns, R., Costa, H. A., Moynihan, K. D., Yeung, Y. A. & Djuretic, I. & 7 others, , Aug 1 2024, In: Nature. 632, 8023, p. 182-191 10 p.Research output: Contribution to journal › Article › peer-review
Open Access12 Scopus citations -
2020
Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration
Sultan, H., Wu, J., Fesenkova, V. I., Fan, A. E., Addis, D., Salazar, A. M. & Celis, E., Sep 21 2020, In: Journal for ImmunoTherapy of Cancer. 8, 2, e001224.Research output: Contribution to journal › Article › peer-review
Open Access45 Scopus citations -
Poly-ICLC, a multi-functional immune modulator for treating cancer
Sultan, H., Salazar, A. M. & Celis, E., Jun 2020, In: Seminars in immunology. 49, 101414.Research output: Contribution to journal › Review article › peer-review
52 Scopus citations -
Role of dendritic cell-mediated immune response in oral homeostasis: A new mechanism of osteonecrosis of the jaw
Elsayed, R., Kurago, Z., Cutler, C. W., Arce, R. M., Gerber, J., Celis, E., Sultan, H., Elashiry, M., Meghil, M., Sun, C., Auersvald, C. M., Awad, M. E., Zeitoun, R., Elsayed, R., Eldin M. Elshikh, M., Isales, C. & Elsalanty, M. E., Feb 1 2020, In: FASEB Journal. 34, 2, p. 2595-2608 14 p.Research output: Contribution to journal › Article › peer-review
Open Access33 Scopus citations -
2019
The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice
Sultan, H., Kumai, T., Nagato, T., Wu, J., Salazar, A. M. & Celis, E., Mar 13 2019, In: Cancer Immunology, Immunotherapy. 68, 3, p. 455-466 12 p.Research output: Contribution to journal › Article › peer-review
Open Access37 Scopus citations -
2018
Role of MDA5 and interferon-I in dendritic cells for T cell expansion by anti-tumor peptide vaccines in mice
Sultan, H., Wu, J., Kumai, T., Salazar, A. M. & Celis, E., Jul 1 2018, In: Cancer Immunology, Immunotherapy. 67, 7, p. 1091-1103 13 p.Research output: Contribution to journal › Article › peer-review
Open Access25 Scopus citations -
Sustained persistence of il2 signaling enhances the antitumor effect of peptide vaccines through t-cell expansion and preventing pd-1 inhibition
Sultan, H., Kumai, T., Fesenkova, V. I., Fan, A. E., Wu, J., Cho, H. I., Kobayashi, H., Harabuchi, Y. & Celis, E., May 2018, In: Cancer immunology research. 6, 5, p. 617-627 11 p.Research output: Contribution to journal › Article › peer-review
Open Access12 Scopus citations -
2017
Designing therapeutic cancer vaccines by mimicking viral infections
Sultan, H., Fesenkova, V. I., Addis, D., Fan, A. E., Kumai, T., Wu, J., Salazar, A. M. & Celis, E., Feb 1 2017, In: Cancer Immunology, Immunotherapy. 66, 2, p. 203-213 11 p.Research output: Contribution to journal › Review article › peer-review
Open Access37 Scopus citations -
Effective antitumor peptide vaccines can induce severe autoimmune pathology
Sultan, H., Trillo-Tinoco, J., Rodriguez, P. & Celis, E., 2017, In: Oncotarget. 8, 41, p. 70317-70331 15 p.Research output: Contribution to journal › Article › peer-review
Open Access11 Scopus citations -
Optimization of peptide vaccines to induce robust antitumor CD4 T-cell responses
Kumai, T., Lee, S., Cho, H. I., Sultan, H., Kobayashi, H., Harabuchi, Y. & Celis, E., Jan 2017, In: Cancer immunology research. 5, 1, p. 72-83 12 p.Research output: Contribution to journal › Article › peer-review
Open Access59 Scopus citations -
2016
CD4 T Cells in Antitumor Immunity
Fesenkova, V., Sultan, H. & Celis, E., Apr 27 2016, Immunity to Pathogens and Tumors. Elsevier Inc., Vol. 4. p. 441-450 10 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
3 Scopus citations -
The effect of α1-antitrypsin deficiency combined with increased bacterial loads on chronic obstructive pulmonary disease pharmacotherapy: A prospective, parallel, controlled pilot study
Hennawy, M. G., Elhosseiny, N. M., Sultan, H., Abdelfattah, W., Akl, Y., Sabry, N. A. & Attia, A. S., Nov 1 2016, In: Journal of Advanced Research. 7, 6, p. 1019-1028 10 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations